Both of the biotech stocks highlighted in today’s article have potential game-changer drugs being reviewed for approval by the FDA – one that could delay the onset of type-1 diabetes in at-risk patients and one that could treat the cognitive decline associated with Alzheimer’s disease. With these potential blockbuster drugs at hand, are these two stocks buys or are investors better off watching from the sidelines? CLICK HERE.
Are These 2 Biotech Stocks With Potential Game-Changer Drugs Being Reviewed For Approval Buys?
- by RobH